Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics

被引:32
|
作者
Haque, Waqar [1 ]
Verma, Vivek [2 ]
Butler, E. Brian [3 ]
Teh, Bin S. [3 ]
机构
[1] CHI St Lukes Hlth, Dept Radiat Oncol, The Woodlands, TX USA
[2] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA
[3] Houston Methodist Hosp, Dept Radiat Oncol, Houston, TX USA
关键词
Bladder cancer; radiation therapy; chemotherapy; chemoradiation; bladder preservation; cystectomy; COMBINED-MODALITY PROGRAM; ORGAN PRESERVATION; II TRIAL; RTOG; CHEMOTHERAPY; RESECTION; SURVIVAL; OUTCOMES; DISPARITIES; CARCINOMA;
D O I
10.21873/anticanres.11994
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The present study sought to compare the differences in practice patterns, as well as clinical outcomes for patients with muscle-invasive bladder cancer undergoing treatment with either radical cystectomy (RC) or concurrent chemoradiaiton (CRT). Patients and Methods: The National Cancer Data Base (NCDB) was queried for patients diagnosed with T2/T3/T4aN0M0 bladder cancer, between 2004-2013, that received definitive treatment with either RC or CRT. Results: 16,960 patients met the inclusion criteria; 1,450 (8.5%) underwent CRT, while 15,510 (91.5%) were treated with RC. Patients undergoing CRT were older, more likely to be female, African American, received treatment at an academic facility, and lived <20 miles of the treatment facility. CRT was associated with worse median OS (32.8 months vs. 36.1 months; p=0.0004). Conclusion: Older patients are more likely to undergo bladder preservation therapy, while those living farther away from treatment facilities are less likely to under CRT.
引用
收藏
页码:5603 / 5608
页数:6
相关论文
共 50 条
  • [41] Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
    D'Andrea, David
    Black, Peter C.
    Zargar, Homayoun
    Zargar-Shoshtari, Kamran
    Soria, Francesco
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Sridhar, Srikala S.
    McGrath, John S.
    Aning, Jonathan
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Grivas, Petros
    Stephenson, Andrew J.
    Shah, Jay B.
    van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Shariat, Shahrokh F.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (12) : 4345 - 4354
  • [42] Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
    Peyrottes, Arthur
    Ouzaid, Idir
    Califano, Gianluigi
    Hermieu, Jean-Francois
    Xylinas, Evanguelos
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [43] Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
    Witjes, J. Alfred
    Feikema, Astrid A. H.
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7833 - 7839
  • [44] Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer
    Patel, Sagar A.
    Liu, Yuan
    Solanki, Abhishek A.
    Baumann, Brian C.
    Efstathiou, Jason A.
    Jani, Ashesh B.
    Chang, Albert J.
    Fischer-Valuck, Benjamin
    Royce, Trevor J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (07) : 325.e15 - 325.e23
  • [45] Hospital length of stay following radical cystectomy for muscle-invasive bladder cancer: Development and validation of a population-based prediction model
    Ray-Zack, Mohamed D.
    Shan, Yong
    Mehta, Hemalkumar B.
    Yu, Xiaoying
    Kamat, Ashish M.
    Williams, Stephen B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (11) : 837 - 843
  • [46] Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Alva, Ajjai S.
    Tallman, Christopher T.
    He, Chang
    Hussain, Maha H.
    Hafez, Khaled
    Montie, James E.
    Smith, David C.
    Weizer, Alon Z.
    Wood, David
    Lee, Cheryl T.
    CANCER, 2012, 118 (01) : 44 - 53
  • [47] UROLOGICAL CANCER Chemoradiation superior in muscle-invasive bladder cancer
    Weiss, Christian
    Roedel, Claus
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (07) : 374 - 375
  • [48] Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
    Royce, Trevor J.
    Feldman, Adam S.
    Mossanen, Matthew
    Yang, Joanna C.
    Shipley, William U.
    Pandharipande, Pari, V
    Efstathiou, Jason A.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (01) : 23 - +
  • [49] Prognostic influence of microsatellite alterations of muscle-invasive bladder cancer treated with radical cystectomy
    Awadalla, Amira
    Harraz, Ahmed M.
    Abol-Enein, Hassan
    Laymon, Mahmoud
    Ahmed, Asmaa E.
    Abdel-Rahim, Mona
    Zekri, Abdel-Rahman N.
    Shokeir, Ahmed A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (02) : 64.e9 - 64.e15
  • [50] Pathological pelvic lymph node involvement in muscle-invasive bladder cancer patients treated with radical cystectomy: A narrative review
    Gabriel, P. -E.
    Pinar, U.
    Parra, J.
    Vaessen, C.
    Mozer, P.
    Chartier-Kastler, E.
    Roupret, M.
    Seisen, T.
    PROGRES EN UROLOGIE, 2023, 33 (03): : 145 - 154